Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Miromatrix to Present at the 2023 ISODP Organ Donation Congress By: Miromatrix Medical Inc. via GlobeNewswire October 11, 2023 at 16:05 PM EDT EDEN PRAIRIE, Minn., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that it will be presenting at the 2023 International Society for Organ Donation and Procurement ("ISODP") Organ Donation Congress in Las Vegas, NV on October 18-21 at Mandalay Bay Resort. M. Mason Macenski, Ph.D, Vice President Clinical and Regulatory Affairs, will be presenting on behalf of Miromatrix on Thursday, October 19 from 2:00pm – 3:00pm PDT. The presentation is titled Maximizing the gift of life: Using perfusion technology to bioengineer multiple transplantable kidneys from a single donor kidney. The ISODP congresses are held every other year in numerous geographic regions of the world to highlight organ donation and transplantation with the intent to share best practices and improve organ donation for that country. About Miromatrix Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com. Investor Contact Greg Chodaczek ir@miromatrix.com Media Contact: Christina Campbell 612-924-3793 Christina@media-minefield.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Miromatrix to Present at the 2023 ISODP Organ Donation Congress By: Miromatrix Medical Inc. via GlobeNewswire October 11, 2023 at 16:05 PM EDT EDEN PRAIRIE, Minn., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that it will be presenting at the 2023 International Society for Organ Donation and Procurement ("ISODP") Organ Donation Congress in Las Vegas, NV on October 18-21 at Mandalay Bay Resort. M. Mason Macenski, Ph.D, Vice President Clinical and Regulatory Affairs, will be presenting on behalf of Miromatrix on Thursday, October 19 from 2:00pm – 3:00pm PDT. The presentation is titled Maximizing the gift of life: Using perfusion technology to bioengineer multiple transplantable kidneys from a single donor kidney. The ISODP congresses are held every other year in numerous geographic regions of the world to highlight organ donation and transplantation with the intent to share best practices and improve organ donation for that country. About Miromatrix Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com. Investor Contact Greg Chodaczek ir@miromatrix.com Media Contact: Christina Campbell 612-924-3793 Christina@media-minefield.com
EDEN PRAIRIE, Minn., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that it will be presenting at the 2023 International Society for Organ Donation and Procurement ("ISODP") Organ Donation Congress in Las Vegas, NV on October 18-21 at Mandalay Bay Resort. M. Mason Macenski, Ph.D, Vice President Clinical and Regulatory Affairs, will be presenting on behalf of Miromatrix on Thursday, October 19 from 2:00pm – 3:00pm PDT. The presentation is titled Maximizing the gift of life: Using perfusion technology to bioengineer multiple transplantable kidneys from a single donor kidney. The ISODP congresses are held every other year in numerous geographic regions of the world to highlight organ donation and transplantation with the intent to share best practices and improve organ donation for that country. About Miromatrix Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com. Investor Contact Greg Chodaczek ir@miromatrix.com Media Contact: Christina Campbell 612-924-3793 Christina@media-minefield.com